surmount-1 tirzepatide obesity nejm 2022 weight loss percent GLP-1 Medications for Loss: Semaglutide vs vs Retat – Revolution Health & Wellness Tirzepatide versus Semaglutide Once Weekly

Under the guidance of a healthcare provider, patients follow a prescribed dosage schedule designed to promote steady and sustainable weight loss

Those in the 35 to 40 BMI range averaged 24.1%, while participants above BMI 40 saw 21.3% reduction

High-protein, high-fiber, hydration and gut health products are also drawing particular interest, especially among younger shoppers

As for heart disease risk markers: triglycerides dropped 37%, waist circumference shrank about 7.5 inches, blood pressure and inflammation markers (hsCRP) also improved

Telehealth followups can help adjust a plan if side effects occur or if symptoms dont improve as expected